General Information of the Protein
Protein ID
PT01127
Protein Name
Protein kinase C theta type
Secondarily
Protein Name
nPKC-theta
Gene Name
PRKCQ
Secondarily
Gene Name
PRKCT
Sequence
MSPFLRIGLSNFDCGSCQSCQGEAVNPYCAVLVKEYVESENGQMYIQKKPTMYPPWDSTFDAHINKGRVMQIIVKGKNVDLISETTVELYSLAERCRKNNGKTEIWLELKPQGRMLMNARYFLEMSDTKDMNEFETEGFFALHQRRGAIKQAKVHHVKCHEFTATFFPQPTFCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCTGSAINSRETMFHKERFKIDMPHRFKVYNYKSPTFCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVANLCGINQKLMAEALAMIESTQQARCLRDTEQIFREGPVEIGLPCSIKNEARPPCLPTPGKREPQGISWESPLDEVDKMCHLPEPELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPGMERLIS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
AGC protein kinase group
>
AGC protein kinase PKC family
>
AGC protein kinase PKC delta subfamily
Function
Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302).
    Show/Hide
Uniprot ID
Primary ID:
Q04759

Secondarily ID:
B4DF52
Q14DH6
Q3MJF1
Q64FY5
Q9H508
Q9H549
    Show/Hide
HGNC ID
HGNC:9410
Subcellular Location
Cytoplasm
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000001 , Jurkat
Compound ID Compound Name Compound Formula
CP0064093
2-[(2-ethylsulfanylpyridin-3-yl)methylamino]-4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C31H43N7OS
 1
1
IC50 < 3 nM
   TI
   LI
   LO
   TS
CP0302863
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[(2-propan-2-ylsulfanylpyridin-3-yl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C32H45N7OS
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0264698
4-[[(3S,5R)-4-(2-hydroxyethylamino)-1-adamantyl]methylamino]-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C26H31F3N6O2
 1
1
IC50 = 6.3 nM
   TI
   LI
   LO
   TS
CP0211335
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[(2-methylsulfanylpyridin-3-yl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C30H41N7OS
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0174875
2,2-dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-1-[(1R)-1-phenylethyl]-3H-quinazolin-4-one
   Show/Hide
C24H23N5O2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0153576
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C31H39F3N6O2
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0549226
1-benzyl-2,2-dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-3H-quinazolin-4-one
   Show/Hide
C23H21N5O2
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0462329
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[(2-methylsulfanylphenyl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C31H42N6OS
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0262273
CHEMBL4594002
   Show/Hide
C31H39F3N6O
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0354938
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[(2-propan-2-yloxypyridin-3-yl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C32H45N7O2
 1
1
IC50 = 18 nM
   TI
   LI
   LO
   TS
CP0360609
4-[[(3S,5R)-4-amino-1-adamantyl]methylamino]-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C24H27F3N6O
 1
1
IC50 = 22 nM
   TI
   LI
   LO
   TS
CP0302862
2-[(2-chlorophenyl)methylamino]-4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C30H39ClN6O
 1
1
IC50 = 22 nM
   TI
   LI
   LO
   TS
CP0251454
4-[[(3S,5R)-4-amino-1-adamantyl]methylamino]-2-[(2-bromophenyl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C23H27BrN6
 1
1
IC50 = 31 nM
   TI
   LI
   LO
   TS
CP0123747
2-[[(1S,3R)-5-[[[5-cyano-2-[[2-(trifluoromethoxy)phenyl]methylamino]pyrimidin-4-yl]amino]methyl]-2-adamantyl]amino]acetamide
   Show/Hide
C26H30F3N7O2
 1
1
IC50 = 41 nM
   TI
   LI
   LO
   TS
CP0266296
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[(2-methoxypyridin-3-yl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C30H41N7O2
 1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
CP0028620
AEB071
   Show/Hide
C25H22N6O2
 1
1
IC50 = 81 nM
   TI
   LI
   LO
   TS
CP0123742
4-[[(3S,5R)-4-amino-1-adamantyl]methylamino]-2-(3-bromoanilino)pyrimidine-5-carbonitrile
   Show/Hide
C22H25BrN6
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0144676
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[(2-methylsulfonylpyridin-3-yl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C30H41N7O3S
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0092203
3-[2-chloro-6-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione
   Show/Hide
C25H20ClN3O2
 1
1
IC50 = 156 nM
   TI
   LI
   LO
   TS
CP0420071
1-(cyclopentylmethyl)-2,2-dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-3H-quinazolin-4-one
   Show/Hide
C22H25N5O2
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0230667
4-[[4-[(4-hydroxycyclohexyl)methylamino]-1-adamantyl]methylamino]-2-[(2-methylsulfinylpyridin-3-yl)methylamino]pyrimidine-5-carbonitrile
   Show/Hide
C30H41N7O2S
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0098156
3-[2-chloro-6-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C26H22ClN3O2
 1
1
IC50 = 185 nM
   TI
   LI
   LO
   TS
CP0092207
3-[2-chloro-7-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C26H22ClN3O2
 1
1
IC50 = 402 nM
   TI
   LI
   LO
   TS
CP0219625
4-[[(3R,5S)-4-amino-1-adamantyl]methylamino]-2-anilinopyrimidine-5-carbonitrile
   Show/Hide
C22H26N6
 1
1
IC50 = 660 nM
   TI
   LI
   LO
   TS
CP0170062
3-[2-chloro-7-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione
   Show/Hide
C25H20ClN3O2
 1
1
IC50 = 708 nM
   TI
   LI
   LO
   TS
CP0204858
1-ethyl-2,2-dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-3H-quinazolin-4-one
   Show/Hide
C18H19N5O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0469592
1-(cyclopropylmethyl)-2,2-dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-3H-quinazolin-4-one
   Show/Hide
C20H21N5O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0549211
2,2-dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-1-(2-phenylethyl)-3H-quinazolin-4-one
   Show/Hide
C24H23N5O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0567580
2,2-dimethyl-1-(2-methylpropyl)-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-3H-quinazolin-4-one
   Show/Hide
C20H23N5O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0115722
3-[2-chloro-7-[[cyclopropyl(methyl)amino]methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C28H24ClN3O2
 1
1
IC50 > 3555 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0028620
AEB071
   Show/Hide
C25H22N6O2
 2
1 IC50 = 0.22 nM
2 IC50 = 1 nM
CP0302863
CHEMBL4547465
   Show/Hide
C32H45N7OS
 1
1 IC50 = 0.23 nM
CP0153576
CHEMBL4580751
   Show/Hide
C31H39F3N6O2
 1
1 IC50 = 0.42 nM
CP0211335
CHEMBL4575526
   Show/Hide
C30H41N7OS
 1
1 IC50 = 0.44 nM
CP0064093
CHEMBL4524977
   Show/Hide
C31H43N7OS
 1
1 IC50 = 0.46 nM
CP0262273
CHEMBL4594002
   Show/Hide
C31H39F3N6O
 1
1 IC50 = 0.57 nM
CP0354938
CHEMBL4439095
   Show/Hide
C32H45N7O2
 1
1 IC50 = 0.59 nM
CP0264698
CHEMBL4289707
   Show/Hide
C26H31F3N6O2
 1
1 IC50 = 0.7 nM
CP0462329
CHEMBL4466775
   Show/Hide
C31H42N6OS
 1
1 IC50 = 0.94 nM
CP0360609
CHEMBL4283768
   Show/Hide
C24H27F3N6O
 1
1 IC50 = 1.3 nM
CP0302862
CHEMBL4464921
   Show/Hide
C30H39ClN6O
 1
1 IC50 = 1.4 nM
CP0123747
CHEMBL4289064
   Show/Hide
C26H30F3N7O2
 1
1 IC50 = 1.9 nM
CP0266296
CHEMBL4441229
   Show/Hide
C30H41N7O2
 1
1 IC50 = 1.9 nM
CP0123742
CHEMBL4287302
   Show/Hide
C22H25BrN6
 1
1 IC50 = 3.9 nM
CP0251454
CHEMBL4281351
   Show/Hide
C23H27BrN6
 1
1 IC50 = 5.9 nM
CP0092203
3-[2-chloro-6-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione
   Show/Hide
C25H20ClN3O2
 1
1 IC50 = 12 nM
CP0098156
3-[2-chloro-6-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C26H22ClN3O2
 1
1 IC50 = 19 nM
CP0219625
CHEMBL4279376
   Show/Hide
C22H26N6
 1
1 IC50 = 28 nM
CP0230667
CHEMBL4592349
   Show/Hide
C30H41N7O2S
 1
1 IC50 = 32 nM
CP0170062
3-[2-chloro-7-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione
   Show/Hide
C25H20ClN3O2
 1
1 IC50 = 216 nM
CP0092207
3-[2-chloro-7-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C26H22ClN3O2
 1
1 IC50 = 263 nM
CP0361044
3,5-dihydro-1H-[1,2,4]triazino[3,4-c][1,4]benzoxazin-2-one
   Show/Hide
C10H9N3O2
 1
1 IC50 = 19000 nM
CP0115722
3-[2-chloro-7-[[cyclopropyl(methyl)amino]methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione
   Show/Hide
C28H24ClN3O2
 1
1 IC50 > 316 nM
CP0115546
(2R)-2-[(2S)-4-[3-chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol
   Show/Hide
C20H24ClFN6O
 1
1 Ki = 0.08 nM
CP0115289
5-fluoro-2-[(3S)-3-[(2R)-2-hydroxy-3-methylbutan-2-yl]piperazin-1-yl]-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-3-ol
   Show/Hide
C20H25FN6O2
 1
1 Ki = 0.1 nM
CP0155925
(2R)-2-[(2S)-4-[3,5-difluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol
   Show/Hide
C20H24F2N6O
 1
1 Ki = 0.1 nM
CP0296536
(2R)-2-[(2S)-4-[5-fluoro-3-(hydroxymethyl)-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol
   Show/Hide
C21H27FN6O2
 1
1 Ki = 0.1 nM
CP0301373
(2R)-2-[(2S)-4-[5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol
   Show/Hide
C20H25FN6O
 1
1 Ki = 0.2 nM
CP0246631
5-fluoro-2-[(3S)-3-[(2R)-2-hydroxy-3-methylbutan-2-yl]piperazin-1-yl]-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridine-3-carbonitrile
   Show/Hide
C21H24FN7O
 1
1 Ki = 1 nM
CP0203505
(2R)-3-methyl-2-[(2S)-4-[6-(2H-pyrazolo[3,4-b]pyridin-3-yl)-5-(trifluoromethyl)pyridin-2-yl]piperazin-2-yl]butan-2-ol
   Show/Hide
C21H25F3N6O
 1
1 Ki = 20 nM
CP0246626
(2R)-2-[(2S)-4-[5-chloro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol
   Show/Hide
C20H25ClN6O
 1
1 Ki = 21 nM
Clinical Information about the Protein
Target 1 ( Protein kinase C theta (PRKCQ) )
Target Type Clinical trial Target
Target 2 ( PKC-theta messenger RNA (PRKCQ mRNA) )
Target Type Literature-reported Target
Disease 1 Target-related Disease  1
1 Human immunodeficiency virus infection [ICD-11: 1C62]
Investigative Drug(s) 1 Investigative Drug  1
1 PROSTRATIN Investigative
Human immunodeficiency virus infection